SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-19-003668
Filing Date
2019-06-27
Accepted
2019-06-27 16:52:41
Documents
1
Period of Report
2019-06-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 3861
  Complete submission text file 0001562180-19-003668.txt   5433
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
Office of Life Sciences

Mailing Address 110 ALLEN ROAD 2ND FLOOR BASKING RIDGE NJ 07920
Business Address
Mazzo David J (Reporting) CIK: 0001334549 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51122 | Film No.: 19926001